logo
ENTITY
BeiGene

BeiGene (6160 HK)

327
Analysis
Health Care • China
BeiGene, Ltd. operates as a commercial stage biopharmaceutical company. The Company focuses on discovery, development, and commercialization of molecularly targeted and immuno-oncology drugs for the treatment of cancer. BeiGene serves patients worldwide.
more
Company Event • 25 Feb 2025 22:30 • Upcoming
Add To Calendar

Q4 2024

Company Event • 12 Nov 2024 22:30 • Upcoming
Add To Calendar

Q3 2024

Company Event • 07 Aug 2024 19:00 • Upcoming
Add To Calendar

Q2 2024

Company Event • 08 May 2024 19:00 • Upcoming
Add To Calendar

Q1 2024

Company Event • 26 Feb 2024 20:00 • Upcoming
Add To Calendar

Q4 2023

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5

x